project id: TCGA-UCEC; case submitter id: TCGA-DI-A1BU; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.1; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20114; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20114; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1195.0; figo stage: Stage IIB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 903; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-DI-A1BU-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;